Diabetic Foot Ulcer Not Healing — Cuba Treatment Options for Pennsylvania Families

A diabetic foot ulcer that has not healed after 4+ weeks of standard wound care is classified as a chronic, non-healing ulcer. In the United States, treatment options for chronic ulcers are limited — typically involving advanced dressings, negative pressure wound therapy, or hyperbaric oxygen therapy, which may or may not be covered by insurance. For many patients, the next step is amputation.

Cuba offers a different option. Heberprot-P (recombinant human epidermal growth factor) is specifically designed for chronic, non-healing diabetic foot ulcers. The growth factor is injected directly into the wound bed, where it stimulates the cell proliferation and angiogenesis needed for healing — processes that are impaired in chronic diabetic wounds. Combined with comprehensive wound care (debridement, infection management, off-loading, vascular assessment), Heberprot-P offers a treatment option for ulcers that have not responded to standard U.S. care.

The program is not a cure, and outcomes vary based on wound severity, vascular status, infection control, and overall health. However, for American patients facing chronic, non-healing ulcers and the prospect of amputation, Cuba's comprehensive approach offers an additional treatment option worth exploring. A medical record review can determine whether Heberprot-P is appropriate for your specific case.